Volume 2, Issue 1 (1-2010)                   IJDO 2010, 2(1): 32-34 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Manaviat M, Chiti Z. Intravitreal Injection of Bevacizumab (Avastin) to Treat Posterior Capsule Neovascularization. IJDO 2010; 2 (1) :32-34
URL: http://ijdo.ssu.ac.ir/article-1-24-en.html
Intravitreal Injection of Bevacizumab (Avastin) to Treat Posterior Capsule Neovascularization
Masoud-Reza Manaviat , Zohreh Chiti *
Abstract:   (4585 Views)
We report a 64-year-old diabetic woman who developed neovascularization of the posterior capsule 2 years after cataract surgery and intraocular lens implantation. The patient was treated with single injection of 1.25 mg of intravitreal bevacizumab (Avastin) via pars plana. After one week, complete regression of the posterior capsule neovascularization was achieved allowing us to perform Nd: YAG capsulotomy without serious complications. Intravitreal injection of bevacizumab can successfully regress the posterior capsule neovascularization resulting in improving patient's visual acuity.
Keywords: Intravitreal injection, Bevacizumab (Avastin), Posterior capsule neovascularization
Full-Text [PDF 128 kb]   (1529 Downloads)    
Type of Study: Research | Subject: General
Received: 2011/08/16 | Published: 2010/01/15
Add your comments about this article : Your username or Email:
CAPTCHA
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Diabetes and Obesity

Designed & Developed by : Yektaweb